| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754384 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 8 Pages |
Abstract
Results of this study suggest that elderly patients with DLBCL experience meaningful PFS with ACRs, but a third experience toxicity requiring therapy modification. Future studies should examine larger patient populations and define treatments with outcomes similar to ACR that also decrease toxicity and hospitalization in the elderly DLBCL population.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Christine C. Davis, Jonathon B. Cohen, Katherine S. Shah, Don A. Hutcherson, Minal J. Surati, Kelly Valla, Elyse H. Panjic, Caitlin E. Handler, Jeffrey M. Switchenko, Christopher R. Flowers,